Company / Current Assets per Share
Arcus Biosciences, Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$10.92
FY2025
5-year range
$10.92 / $19.38
FY2021-FY2025
Trend
-18.8%
vs FY2024
Sector context
#71 of 210
Health Care
What the data says
At $10.92, Arcus Biosciences, Inc.'s current assets per share ranks #71 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 9 years, ranging from $4.33 in FY2019 to $96.74 in FY2017.
Based on SEC 10-K filings.
10.92 in FY2025 with a 5-year CAGR of -7.4%.
Declined from $11.40 to $10.92 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.2%
- 5-Year CAGR
- -7.4%
- 10-Year CAGR
- -
Sector benchmark
#71 of 210 in Health CareTop 34% of 210This company $10.92 Sector average $170.65
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 18.8% year-over-year.
- Ranks #71 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2017.
- Lowest current assets per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.92 | -18.8% |
| FY2024 | $13.46 | +18.1% |
| FY2023 | $11.40 | -24.4% |
| FY2022 | $15.07 | -22.2% |
| FY2021 | $19.38 | +21.0% |
| FY2020 | $16.02 | +270.3% |
| FY2019 | $4.33 | -93.2% |
| FY2018 | $63.30 | -34.6% |
| FY2017 | $96.74 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026